Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperinsulinism × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Polycystic Ovary Syndrome 4 Prostatic Neoplasms 2 Solid Tumors 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Obesity 1 Lung Neoplasms 1 Inflammation 1 Hyperinsulinism 1 Heart Failure 1 Cardiotoxicity 1 Adenocarcinoma of Lung 1

Interventions

fluorodopa F 18 3 pasireotide 1 dapagliflozin 1 amino-acid, glucose, and electrolyte solution 1 Solutions 1 Saline Solution 1 Pioglitazone 1 Insulin 1 Injections 1 Diazoxide 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05989347 2025-03-19

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Yale University

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡